... and a vocal critic of runaway drug pricing and drug profiteering, today criticized Gilead Sciences , the leading HIV/AIDS drug maker, and its CEO for continuing their practice of pillaging U.S. taxpayers as a means to fund the company's unbridled ...
http://ift.tt/1fDRyeh
http://ift.tt/1fDRyeh
No comments:
Post a Comment